UNSPSC 51422306: Dexamethasone

This classification denotes a therapeutic glucocorticoid and antiemetic agent with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7S5I7G3JQL, chemically known as 9-fluoro-11.beta.,17, 21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione but generally known as dexamethasone, which bears US NIH Compound Identifier 3003. European Medicines Agency schedules Dexamethasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07017MIG.

UNSPSC 51422306 Dexamethasone is a Commodity code, but the recent state and local opportunities posted under it do not reflect dexamethasone procurement. Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) solicits naloxone and drug deactivation systems for community health initiatives, while the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) explores direct-to-manufacturer prescription programs without specifying drug categories. Neither opportunity aligns with dexamethasone, a corticosteroid pharmaceutical used in clinical and emergency settings. The code shows little relevant recent activity in state and local procurement.

The mismatch between the UNSPSC code designation and actual solicitation scope suggests either miscategorization at posting or that dexamethasone procurement does not appear in recent state and local contract notices under this code. Business development professionals tracking dexamethasone supply should verify category assignments with individual issuing bodies or monitor related pharmaceutical-supply codes rather than relying on the posted opportunities here.